Status: current, Defined. Date: 31-Oct 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2976271000168111 | Tecentriq (atezolizumab 1.2 g / 20 mL) injection, 1 x 20 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2976281000168114 | Tecentriq 1.2 g/20 mL injection, 20 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | Is a | atezolizumab 1.2 g / 20 mL injection, 1 x 20 mL vial (medicinal product pack) | true | Inferred relationship | Some | ||
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | has TPUU | Tecentriq 1.2 g/20 mL injection, 20 mL vial | true | Inferred relationship | Some | 1 | |
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | has TP | Tecentriq | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Tecentriq 1.2 g/20 mL injection, 20 mL vial | Is a | True | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR